Esomeprazole and omeprazole could possibly boost the serum concentrations of benzodiazepines (through CYP2C19 inhibition) bringing about enhanced adverse effects for instance drowsiness, Even though the clinical relevance is minimal in the majority of clients – monitor the patient for adverse effects (e.If affected person cannot resume their regu